| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031143948 |
| P356 | DOI | 10.1038/NATURE05441 |
| P698 | PubMed publication ID | 17159889 |
| P50 | author | Rob Boer | Q46809417 |
| Kathryn P Derose | Q55908492 | ||
| Jeffrey Wasserman | Q88900856 | ||
| P2093 | author name string | Federico Girosi | |
| Emmett Keeler | |||
| Karen A Ricci | |||
| Carol A Dahl | |||
| Deborah C Hay Burgess | |||
| Stuart S Olmsted | |||
| Lee Hilborne | |||
| Yee-Wei Lim | |||
| Christopher M Beighley | |||
| Julia E Aledort | |||
| Maria E Rafael | |||
| Molly V Shea | |||
| P2860 | cites work | Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics | Q37860760 |
| Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics | Q59057931 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3-8 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Developing and interpreting models to improve diagnostics in developing countries | |
| P478 | volume | 444 Suppl 1 |
| Q30433134 | Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate |
| Q36299527 | Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health |
| Q44421311 | An electrochemical Lab-on-a-CD system for parallel whole blood analysis |
| Q38197212 | Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects. |
| Q34100076 | Assessment of the proportion of neonates and children in low and middle income countries with access to a healthcare facility: A systematic review |
| Q92915568 | Challenges and Opportunities of Centrifugal Microfluidics for Extreme Point-of-Care Testing |
| Q53824849 | Clinical bacteriology in low-resource settings: today's solutions. |
| Q37985623 | Commercialization of microfluidic point-of-care diagnostic devices |
| Q37620312 | Considerations for an Access-Centered Design of the Fever Thermometer in Low-Resource Settings: A Literature Review |
| Q38859651 | Consolidating HIV testing in a public health laboratory for efficient and sustainable early infant diagnosis (EID) in Uganda |
| Q41903839 | CrAg lateral flow assay for cryptococcosis |
| Q35661898 | Defining the needs for next generation assays for tuberculosis |
| Q33768704 | Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans |
| Q34607842 | Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads |
| Q41849725 | Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis? |
| Q35606872 | Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics |
| Q54310253 | Evaluating the thermostability of commercial fast real-time PCR master mixes. |
| Q35200885 | Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer. |
| Q46313072 | Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics |
| Q36394909 | Gold nanoparticle aggregation for quantification of oligonucleotides: optimization and increased dynamic range |
| Q59326977 | How to implement new diagnostic products in low-resource settings: an end-to-end framework |
| Q42643697 | Integrated community case management by drug sellers influences appropriate treatment of paediatric febrile illness in South Western Uganda: a quasi-experimental study |
| Q33465218 | Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications |
| Q30476297 | Nano/Microfluidics for diagnosis of infectious diseases in developing countries |
| Q41990079 | Novel biochip platform for nucleic acid analysis |
| Q36159045 | On-chip Extraction of Intracellular Molecules in White Blood Cells from Whole Blood |
| Q35907384 | Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis |
| Q37092106 | Perspective on diagnostics for global health |
| Q35207820 | Point-of-care and point-of-procedure optical imaging technologies for primary care and global health |
| Q38375684 | Potential market for novel tuberculosis diagnostics: worth the investment? |
| Q39167527 | Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening |
| Q59097874 | Reducing stunting among children: the potential contribution of diagnostics |
| Q46472414 | Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics |
| Q39377270 | Reducing the burden of childhood malaria in Africa: the role of improved |
| Q37860760 | Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics |
| Q46410650 | Reducing the global burden of tuberculosis: the contribution of improved diagnostics |
| Q44017535 | Requirements for high impact diagnostics in the developing world |
| Q46949758 | Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries |
| Q38427904 | Strengthening laboratory systems in resource-limited settings. |
| Q55332922 | Utilization of fine needle aspiration cytology at Kamuzu central hospital. |
Search more.